XETRA - Delayed Quote EUR

Intuitive Surgical, Inc. (IUI1.DE)

Compare
534.00
+4.60
+(0.87%)
At close: January 10 at 5:36:00 PM GMT+1
Loading Chart for IUI1.DE
DELL
  • Previous Close 529.40
  • Open 529.10
  • Bid 533.70 x --
  • Ask 534.70 x --
  • Day's Range 526.20 - 534.00
  • 52 Week Range 327.85 - 534.00
  • Volume 249
  • Avg. Volume 399
  • Market Cap (intraday) 190.2B
  • Beta (5Y Monthly) 1.39
  • PE Ratio (TTM) 88.56
  • EPS (TTM) 6.03
  • Earnings Date Jan 23, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

www.intuitive.com

13,676

Full Time Employees

December 31

Fiscal Year Ends

Recent News: IUI1.DE

View More

Performance Overview: IUI1.DE

Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

IUI1.DE
4.36%
S&P 500
1.35%

1-Year Return

IUI1.DE
76.73%
S&P 500
22.51%

3-Year Return

IUI1.DE
85.67%
S&P 500
24.59%

5-Year Return

IUI1.DE
5,886.55%
S&P 500
77.94%

Compare To: IUI1.DE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IUI1.DE

View More

Valuation Measures

As of 1/10/2025
  • Market Cap

    189.37B

  • Enterprise Value

    185.26B

  • Trailing P/E

    88.40

  • Forward P/E

    70.92

  • PEG Ratio (5yr expected)

    4.08

  • Price/Sales (ttm)

    25.21

  • Price/Book (mrq)

    12.57

  • Enterprise Value/Revenue

    24.25

  • Enterprise Value/EBITDA

    75.56

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    28.51%

  • Return on Assets (ttm)

    7.95%

  • Return on Equity (ttm)

    15.97%

  • Revenue (ttm)

    7.87B

  • Net Income Avi to Common (ttm)

    2.24B

  • Diluted EPS (ttm)

    6.03

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.23B

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    637.52M

Research Analysis: IUI1.DE

View More

People Also Watch